Titan BiotechBOM:524717 +2.62%58 OCF Yield % is 1.84 as of Jul. 13, 2026, which is 73% below its 10-year median of 6.75. GuruFocus rates BOM:524717 with a GF Score™ of 58/100 and a GF Value™ of ₹144.79 (Significantly Overvalued). The stock has 2 warning signs investors should review. Among 1,410 Biotechnology companies, Titan Biotech ranks better than 83.55% on this metric.
OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.
Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Titan Biotech OCF Yield % Related Terms
Titan Biotech OCF Yield % Historical Data
* Premium members only.
The historical data trend for Titan Biotech's OCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:524717 vs VRTX, REGN, ALNY: OCF Yield % Comparison
For the Biotechnology subindustry, Titan Biotech's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Titan Biotech OCF Yield % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Titan Biotech's OCF Yield % distribution charts can be found below:
* The bar in red indicates where Titan Biotech's OCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Titan Biotech (BOM:524717) has a OCF Yield % of 1.84 as of Jul. 13, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Titan Biotech and its competitors. This is 73% below median its historical median of 6.75. Over the past decade, Titan Biotech's OCF Yield % has ranged from 1.50 to 31.77. According to the industry distribution chart, Titan Biotech ranks #232 out of 1410 companies in the Biotechnology industry, placing it in the top 16.5%.
Is Titan Biotech's OCF Yield % too high?
Titan Biotech's current OCF Yield % of 1.84 is 73% below median its 10-year median of 6.75. Over the past 10 years, this metric has ranged from a low of 1.50 to a high of 31.77. Based on the distribution chart, Titan Biotech ranks #232 out of 1410 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Titan Biotech has a GF Score™ of 58/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Titan Biotech's OCF Yield % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Titan Biotech ranks #232 out of 1410 companies for OCF Yield %. This places Titan Biotech in the top 17% of its industry — outperforming the majority of peers. Historically, Titan Biotech's own OCF Yield % has ranged from 1.50 to 31.77 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Biotechnology company?
A good OCF Yield % depends on the Biotechnology industry context. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Titan Biotech and its competitors. Titan Biotech's current OCF Yield % is 1.84, which is 73% below median its own 10-year median of 6.75. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Titan Biotech stock overvalued right now?
Based on GuruFocus' analysis, Titan Biotech (BOM:524717) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹144.79, compared to a current price of ₹400.95 — trading 176.9% above its estimated fair value. The current OCF Yield % is 1.84, which is 73% below median its 10-year median of 6.75. Titan Biotech's overall GF Score™ is 58/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Titan Biotech (BOM:524717), the current OCF Yield % is 1.84 as of Jul. 13, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Titan Biotech (BOM:524717) Overvalued in 2026?
Based on GuruFocus' analysis, Titan Biotech stock appears to be overvalued.
The current stock price of ₹400.95 is trading 176.9% above its estimated GF Value™ of ₹144.79.
GuruFocus considers Titan Biotech to be Significantly Overvalued.
Key valuation signals for BOM:524717:
OCF Yield %: 1.84 (73% below median its 10-year median of 6.75)
GF Value™: ₹144.79 vs. price of ₹400.95 (176.9% above fair value)
No single metric tells the full story. See the BOM:524717 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Titan Biotech Ltd is a manufacturer and exporter of biological products. It manufactures biological products such as peptone, malt extract, yeast extract, liver extract, bile extract, culture media, laboratory chemicals, plant growth promoters, and others. The biological products have applications in the field of pharmaceutical, nutraceutical, food and beverages, biotechnology and fermentation, cosmetic, veterinary and animal feed, agriculture industries, and others. The company's business activity falls within a single primary business segment, which is the business of Biological Products. The firm sells its products in India and also exports internationally, of which the majority of the revenue is derived from the sales made in India.
58GF Score
Get the complete analysis for BOM:524717
OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:524717 has been successfully added to your 
